During this year´s AACR Annual Meeting, Washington DC, April 6 -10, ecancer caught up with VHIO´s Laura Soucek, PI of the Mouse Models of Cancer Therapies Group, to discuss her group´s pioneering work on Myc inihibition in pre-clinical mouse models.
Related Posts
An interview with Ana Vivancos, Principal Investigator of VHIO´s Cancer Genomics Group “We are one of the few groups in…
For many decades, cancer research in Europe has been heavily fragmented, inefficient and duplicating work. Now, long-term collaborations have been…
Latest research at VHIO confirms 4 subgroups of HER2+ breast cancer with different molecular characteristics The diagnostic test for these…
Barcelona, 17 July 2015. – Last week, 10 July, marked the second Vall d´Hebron Research Institute (VHIR) Health Innovation Contest,…
Source: Princess Margaret Cancer Centre TORONTO, Canada – Feb. 27, 2015 – Two internationally acclaimed cancer centres today announced a…
During this year´s Annual Meeting of the American Society of Clinical Oncology (ASCO), that came to a close yesterday in…
During last month´s WIN – Worldwide Innovative Networking in personalized cancer medicine, Symposium, June 29 – 30, Paris, France, ecancer…
CALL FOR APPLICATIONS 2012 The objective of the Fellowship is to provide support to two outstanding MD’s, PhD’s, or MD/PhD’s…
Between 50 – 75% of the most common hereditary cancers (breast and colon) escape the diagnostic ´lens´ when only factoring…
VHIO opens its doors to bright young minds to learn about cancer research and discover science as a career path…
In a recent Perspectives/Opinion article* published online in Nature Reviews Cancer, members of the EurOPDX Consortium, including VHIO´s Joaquín Arribas,…
IMPORTANT NOTIFICATION: As an update to this earlier news item (see below), Pau´s fundraising concert on the 22nd December is…
It is the first National Agreement that includes the Academic environment, basic research, clinical research and the pharmaceutical industry
While the ever-advancing landscape of precision medicine in oncology undoubtedly brings fresh hope for patients, it also poses many yet…
• The BBVA Foundation backs research aimed at preclinically validating recently reported findings that established Omomyc as a potential…